期刊文献+

Advances in artificial intelligence techniques drive the application of radiomics in the clinical research of hepatocellular carcinoma

原文传递
导出
摘要 Hepatocellular carcinoma(HCC)remains the most common malignancy to threaten public health globally.With advances in artificial intelligence techniques,radiomics for HCC management provides a novel perspective to solve unmet needs in clinical settings,and reveals pixel-level radiological information for medical imaging big data,correlating the radiological phenotype with targeted clinical issues.Conventional radiomics pipelines depend on handcrafted engineering features,and further deep learning-based radiomics pipelines are supplemented with deep features calculated via self-learning strategies.During the past decade,radiomics has been widely applied in accurate diagnoses and pathological or biological behavior evaluation,as well as in prognosis prediction.In this review,we systematically introduce the main pipelines of artificial intelligence-based radiomics and their efficacy in the clinical studies of HCC.
出处 《iLIVER》 2022年第1期49-54,共6页 国际肝胆健康(英文)
基金 This study has received funding by the National Key Research and Development Program of China under Grant 2017YFA0700401 and 2021YFC2500402 Ministry of Science and Technology of China under Grant No.2017YFA0205200 National Natural Science Foundation of China under Grant No.82001917,81930053,82090052,82090051,82093219055,81227901,92159202 and 81527805 Beijing Natural Science Foundation under Grant No.L192061 the Project of High-Level Talents Team Introduction in Zhuhai City。
  • 相关文献

参考文献3

共引文献713

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部